North America dominates the Vaporized Hydrogen Peroxide (VHP) Decontamination Systems market, accounting for 35% of global revenue. The regionโs mature healthcare infrastructure, stringent regulatory frameworks (e.g., FDA protocols), and high adoption of advanced sterilization technologies drive growth. Investments in pharmaceutical R&D and biocontainment facilities further accelerate demand. Europe follows with 25%, fueled by robust healthcare policies (EU GMP guidelines), aging demographics, and cross-border collaborations between biotech firms and decontamination providers. The Asia Pacific region, projected as the fastest-growing market, holds 20% share, driven by rising healthcare expenditure, expanding pharmaceutical manufacturing hubs, and government initiatives to modernize sterilization practices in China, India, and Japan. Latin America (15%) and the Middle East & Africa (5%) exhibit incremental growth, supported by improving healthcare access, gradual regulatory adoption, and investments in hospital infrastructure.